TEL AVIV, Israel
June 15, 2012
InspireMD, Inc. (OTC BB: NSPR) (the "Company" or "InspireMD"), a medical device company focusing on the development and commercialization of its proprietary stent platform technology for use in patients with Acute Myocardial Infarctions, announced today that
, Chief Financial Officer, will present at the Marcum MicroCap Conference on
New York City
. The event is hosted by Marcum LLP, one of the top ten auditors of U.S. public companies.
- Date: Wednesday, June 20, 2012
- Time: 10:30AM
- Location: The Hudson Suite at The Roosevelt Hotel, 45 East 45th Street, New York, NY
Presenting on behalf of InspireMD will be
About the Marcum Microcap Conference
The Marcum MicroCap Conference is dedicated to introducing investors to the very best, undiscovered companies under
in market capitalization. The event is targeted at top fund managers and qualified high net worth investors who focus on small cap equities. More than 500 participants are expected this year, including institutional investors, mutual funds, hedge funds, wealth managers, and family offices. Industries featured include Life Sciences, Technology, Media & Telecom, Social Media & Internet, Consumer, Metals & Mining Industrials and Energy. The conference will also include panel discussions focused on issues that are of key interest to the financial community involved with micro and small-cap growth companies. Marcum LLP is one of the largest independent public accounting and advisory services firms in the U.S.The event is being co-hosted by CCG Investor Relations, a global investor relations consulting firm.
The conference is free to attend for qualified investors. For full event details and registration information, please click here:
About InspireMD, Inc.